Showing results (631-640 of 687) with videos related to

Sort By:
Pageof 69
Nature Communications|October 20, 2025
Mitochondrial one-carbon metabolism is required for TGF-β-induced glycine synthesis and fibrotic responsesAngelo Y Meliton, Kun Woo D Shin, Rengül Cetin-Atalay, et al.
Molecular and Cellular Biology|May 8, 2001
Selective inhibition of selenocysteine tRNA maturation and selenoprotein synthesis in transgenic mice expressing isopentenyladenosine-deficient selenocysteine tRNAM E Moustafa, B A Carlson, M A El-Saadani, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 25, 2019
[The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma]W J Ni, W Deng, Z F Xiao, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|September 17, 2021
[Adherence to adjuvant with therapy imatinib in patients with gastrointestinal stromal tumor: a national multi-center cross-sectional study]P Zhang, J Zhang, B Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2019
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432F Wang, X L Wei, F H Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Topical Steroid Withdrawal is a Targetable Excess of Mitochondrial NADNadia Shobnam, Sarini Saksena, Grace Ratley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trialM Untch, R D Gelber, C Jackisch, et al.
The Journal of Investigative Dermatology|March 15, 2025
Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NADNadia Shobnam, Grace Ratley, Sarini Saksena, et al.
British Journal of Cancer|July 2, 2025
Chemotherapy-induced neuropathy in monomethyl Auristatin E treatment: prevention by lithiumMatheus F Itaborahy, Isadora Z L F Feng, Uri F Vieira-Machado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized studyY K Shi, L Wang, B H Han, et al.
Pageof 69